Verastem, Inc. Convertible Preferred Stock, Shares Issued upon Conversion
Verastem, Inc. (VSTM) had Convertible Preferred Stock, Shares Issued upon Conversion of 11.74 million shares as of 2012-09-30, per its 10-Q filed 2012-11-13.
Discontinued › Notes › Stockholders' Equity Note
us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion · last filed 2015-03-10
- 2012-09-30: Convertible Preferred Stock, Shares Issued upon Conversion 11.74M shares.
- 2012-06-30: Convertible Preferred Stock, Shares Issued upon Conversion 11.74M shares.
- 2012-02-29: Convertible Preferred Stock, Shares Issued upon Conversion 11.74M shares.
- 2012-02-28: Convertible Preferred Stock, Shares Issued upon Conversion 11.74M shares.
| Period end | Convertible Preferred Stock, Shares Issued upon Conversion |
|---|---|
| 2012-09-30 | 11.74M shares 10-Q · filed 2012-11-13 |
| 2012-06-30 | 11.74M shares 10-Q · filed 2012-08-13 |
| 2012-02-29 | 11.74M shares 10-K · filed 2015-03-10 |
| 2012-02-28 | 11.74M shares 10-K · filed 2013-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 |